Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 6/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.40 |
| ▸ | RAB9A | P51151 | 4/20 | 0.40 |
| ▸ | NPC1 | O15118 | 4/20 | 0.40 |
| ▸ | GAA | P10253 | 3/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 8/20 | 0.33 |
| ▸ | MEN1 | O00255 | 7/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.33 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.32 |
| ▸ | HPGD | P15428 | 2/20 | 0.32 |
| ▸ | POLB | P06746 | 2/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | BCHE | P06276 | 1/20 | 0.32 |
| ▸ | PTPRC | P08575 | 1/20 | 0.32 |
| ▸ | THRB | P10828 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11973972 | 1.00 | MAPT (0.40) | MAPTALDH1A1RAB9ANPC1GAA | |
| SCHEMBL11974570 | 0.91 | MAPT (0.34) | MAPTALDH1A1RAB9ANPC1GAA | |
| SCHEMBL630098 | 0.91 | MAPT (0.34) | MAPTALDH1A1RAB9ANPC1GAA | |
| SCHEMBL2312130 | 0.84 | MAPT (0.56) | MAPTALDH1A1RAB9ANPC1GAA | |
| SCHEMBL11876770 | 0.84 | MAPT (0.56) | MAPTALDH1A1RAB9ANPC1GAA | |
| SCHEMBL19322469 | 0.78 | TP53 (0.42) | MAPTALDH1A1RAB9ANPC1GAA | |
| SCHEMBL11877584 | 0.78 | TP53 (0.42) | MAPTALDH1A1RAB9ANPC1GAA | |
| SCHEMBL332277 | 0.78 | TP53 (0.42) | MAPTALDH1A1RAB9ANPC1GAA | |
| SCHEMBL11877590 | 0.78 | TP53 (0.42) | MAPTALDH1A1RAB9ANPC1GAA | |
| SCHEMBL2389884 | 0.76 | ALDH1A1 (0.42) | MAPTALDH1A1RAB9ANPC1GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 55 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122070916-A | Application of arteannuin with double functions in promoting liver cell maturation and relieving liver lipid metabolism dysfunction | 广州市第一人民医院（广州消化疾病中心、广州医科大学附属市一人民医院、华南理工大学附属第二医院） | 2026-05-22 | — | — | CN | disclosed |
| US-20250057808-A1 | COMPOSITION COMPRISING BETA LACTAM FOR TREATING ALCOHOL DEPENDENCE AND ALCOHOL ASSOCIATED DISEASES OR CONDITIONS | UNIVERSITY OF TOLEDO | 2025-02-20 | — | — | US | disclosed |
| EP-4380904-A1 | MIXED-MATRIX COMPOSITE INTEGRATED FIBER OPTIC CO2 SENSOR | Battelle Memorial Institute (US) | 2024-06-12 | — | — | EP | disclosed |
| US-12005090-B2 | Probiotic composition including lactic acid bacterial strains and use of at least one of such strains | GLAC BIOTECH CO., LTD. (TW) | 2024-06-11 | — | — | US | disclosed |
| US-20230399422-A1 | ADDITIVE MANUFACTURING POLYELECTROLYTE RESIN AND ADDITIVELY MANUFACTURING | GOVERNMENT OF THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF COMMERCE | 2023-12-14 | — | — | US | disclosed |
| CN-116217663-A | Antioxidant polypeptide KFTCAP derived from haematococcus pluvialis, preparation method and application | 华南农业大学 | 2023-06-06 | — | — | CN | disclosed |
| CN-116121190-A | Induction culture solution for inducing stem cells into midbrain dopaminergic neuron precursor cells, application thereof and induction method | 同济大学 | 2023-05-16 | — | — | CN | disclosed |
| US-11583373-B2 | Coloured curable composition for additive manufacturing processes, 3-dim composite article and use thereof | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2023-02-21 | — | — | US | disclosed |
| US-20230039427-A1 | Mixed-matrix composite integrated fiber optic CO2 sensor | BATTELLE MEMORIAL INSTITUTE | 2023-02-09 | — | — | US | disclosed |
| WO-2023015044-A1 | MIXED-MATRIX COMPOSITE INTEGRATED FIBER OPTIC CO2 SENSOR | BATTELLE MEMORIAL INSTITUTE (US) | 2023-02-09 | — | — | WO | disclosed |
| EP-1878756-A1 | Labeled tackifiers | National Starch and Chemical Investment Holding Corporation (US) | 2008-01-16 | — | — | EP | disclosed |
| US-20080009573-A1 | Labeled tackifiers | NATIONAL STARCH AND CHEMICAL INVESTMENT HOLDING CORP. | 2008-01-10 | — | — | US | disclosed |
| US-20070154621-A1 | METHODS FOR COATING SURFACES WITH ANTIMICROBIAL AGENTS | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM | 2007-07-05 | — | — | US | disclosed |
| WO-2006136423-A2 | MEDICAMENT FOR THE TREATMENT OF IMPAIRED GLUCOSE METABOLISM | DSM IP ASSETS B.V. (NL) | 2006-12-28 | — | — | WO | disclosed |
| WO-2006136429-A1 | COMPOUNDS FOR THE TREATMENT OF NON-AUTOIMMUNE TYPE 2 DIABETES MELLITUS AND/OR SYNDROME X | DSM IP ASSETS B.V. (NL) | 2006-12-28 | — | — | WO | disclosed |
| US-20050197634-A1 | Methods for coating and impregnating medical devices with antiseptic compositions | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM | 2005-09-08 | — | — | US | disclosed |
| EP-0481519-B1 | Standard samples and methods of instrumental measurement of ASTM color of petroleum products using said samples | NIPPON PETROLEUM REFINING CO (JP) | 1995-01-11 | — | — | EP | disclosed |
| US-5381227-A | Solutions of azo and anthraquinone dyes | NIPPON PETROLEUM REFINING CO., LTD. (JP) | 1995-01-10 | — | — | US | disclosed |
| US-5139330-A | Oxidation resistance, color stability | NIPPON PETROLEUM REFINING CO., LTD. (JP) | 1992-08-18 | — | — | US | disclosed |
| EP-0481519-A1 | Standard samples and methods of instrumental measurement of ASTM color of petroleum products using said samples | NIPPON PETROLEUM REFINING COMPANY, Ltd. (JP) | 1992-04-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250057808-A1 | COMPOSITION COMPRISING BETA LACTAM FOR TREATING ALCOHOL DEPENDENCE AND ALCOHOL ASSOCIATED DISEASES OR CONDITIONS | ADH1A, ADH1C, SLC10A1 | MAPT 1038/4885ALDH1A1 41/4885RAB9A 822/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.